Action is being taken to establish an equipment rental agreement, service support, and consumables contract to provide patient care support for 40 point-of-care testing (poct) sites.

Ended Awarded Last action

Contract number
HT001425FE009
Awardee
Awarding agency
Obligated
$249,996

Award facts

Contract value 100% obligated
$249,995.50 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 · Equipment rental and consumables contract for 40 point-of-care testing sites. $0
Other Administrative Action P00001 · Provide patient care support for 40 point-of-care testing (poct) sites $0
Original award $249,996

About this award

The Defense Health Agency has awarded a delivery order to Abbott Laboratories Inc., through its Point of Care division, to establish an equipment rental agreement, service support, and consumables contract supporting 40 point-of-care testing (POCT) sites. The contract, valued at approximately $250K with a firm fixed-price structure, extends through October 27, 2026, and was awarded on September 28, 2025, without a set-aside designation. The place of performance is Bethesda, Maryland. This delivery order is issued under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) Master Schedule, which streamlines federal procurement of diagnostic and laboratory testing equipment and services.

Abbott Laboratories, a global healthcare company headquartered in North Chicago, Illinois, maintains an established presence as a primary federal supplier of point-of-care testing devices, clinical laboratory analyzers, and diagnostic reagents. The company's Abbott Point of Care division specializes in portable blood analyzers, glucose monitoring systems, and related consumables widely deployed across the Department of Veterans Affairs and Defense Health Agency networks. Abbott's contracting approach emphasizes cost-per-test and cost-per-reportable-result pricing models that align with government efficiency objectives. The company holds multiple blanket purchase agreements across GSA Schedules and numerous Veterans Integrated Service Networks, positioning it as a critical supplier for federal healthcare diagnostic support.

Quick answers

Who was awarded contract HT001425FE009?

HT001425FE009 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on September 28, 2025.

How much is contract HT001425FE009 worth?

The government has obligated $249,996 on HT001425FE009.

Is contract HT001425FE009 an order under another contract?

Yes. HT001425FE009 is a delivery order under V797P7322A, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract HT001425FE009 competed?

The extent of competition for HT001425FE009 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award